In vitro Combination Studies of Antibiotics against Bacterial Pathogens
Schlagwörter:
Antibiotics, fractional inhibitory concentration, mutation prevention concentration, rifampicin, synergismAbstract
Antibiotic-resistant microorganisms are emerging worldwide and causing serious complications. As these microorganisms are resistant to most of the contemporary antibiotics, their control is becoming as a global health concern. Therefore, there is a need for new alternative compounds or strategies that are effective against these microbial infections and in preventing or delaying their resistance. This study was carried out to test Rifampicin as an adjuvant therapeutic agent in the treatment of infections caused by Gram-positive as well as negative Bacteria. For this purpose, two antibiotics — Doxycycline and Ciprofloxacin — were studied in combination with Rifampicin. Fractional inhibitory concentration index showed synergistic effect when Rifampicin is used in combination with Doxycycline and the effect was found to be additive in nature when used in combination with ciprofloxacin. Hence, Rifampicin in combination with Doxycycline is considered to be better than the combination of Rifampicin and Ciprofloxacin. This is also confirmed by mutation prevention concentration results where Rifampicin had Mutation Prevention Concentration (MPC) greater than 256 µg/ml against all the pathogens included in study but when Rifampicin was used in combination with 1 µg/ml Doxycycline, the concentration of Rifampicin was reduced to 16 µg/ml while in combination with Ciprofloxacin, its concentration was 32 µg/ml against S. aureus ATCC 29213. The synergistic combinatory effect of the given antibiotics was studied only for S. aureus to understand the dynamic drug combination response. S. aureus is one of the major causes of nosocomial and community infections. It has shown resistance to most of the currently available antibiotics.Veröffentlicht
Ausgabe
Rubrik
Lizenz
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |